Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2013/05/003705
CTRI/2013/05/003705
Completed
Phase 2

A comparative clinico-experimental evaluation of Rasayana Drugs administered orally & by Basti in the management of Madhumeha w. s. r. to Type-II Diabetes Mellitus

Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Type 2 Diabetes Mellitus

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Type 2 Diabetes Mellitus
Sponsor
Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar
Enrollment
100
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar

Eligibility Criteria

Inclusion Criteria

  • •Patient of NIDDM with blood sugar level,
  • •FBS\- 126 to 220 mg/dl or
  • •PPBS\- 180 to 300 mg/dl.

Exclusion Criteria

  • •Patients having age less than 20 years \& above 60 years.
  • •Patients of Type\-I Diabetes or the patients of Type\-II Diabetes taking Insulin.
  • •Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot, Carbuncles etc.
  • •Patients having Diabetes in association with other endocrinopathies like Phaeochromocytoma, Acromegaly, Cushingâ??s syndrome, hyperthyroidism etc.
  • •Patients having drug or chemical induced Type II Diabetes, like glucocorticoids induced or thyroid hormone induced etc.
  • •Patients with genetic syndromes associated with Type II Diabetes like Downâ??s Syndrome, Klinefelterâ??s Syndrome, Turnerâ??s Syndrome etc.
  • •Patients complicated with any Cardiovascular diseases, Renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.
  • •Patients contraindicated for Bastikarma as per classics

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
A comparative evaluation of nasal (Nasya Karma) and oral administration of Brahmi Ghrita in healthy volunteers to evaluate theMemory boosting effect.
CTRI/2015/08/006086Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar100
Not yet recruiting
Phase 3
A clinical trial to compare the efficacy of various esthetic crowns in primary posterior teeth requiring full coverage restorations.
CTRI/2024/07/071685Dr Ankita Mishra
Recruiting
Phase 3
Evaluation of the effect of TauroLock™ and piperacillin-tazobactam in secondary prophylaxis of Port-Catheter infection.Infection due to port catheter.Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
IRCT20180309039013N1Shiraz University of Medical Sciences50
Completed
Not Applicable
Treatment of gum deficiency using two layered membrane prepared from bloodHealth Condition 1: K060- Gingival recession
CTRI/2022/07/044099Anupama Tadepalli45
Not yet recruiting
Not Applicable
A study on patients to compare the effect of satranidazole and ornidazole medicine in the treatment of gum diseaseHealth Condition 1: K053- Chronic periodontitis
CTRI/2019/06/019522P Bhavana